SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-002437
Filing Date
2020-05-15
Accepted
2020-05-15 10:48:26
Documents
7
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 8068
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 442540
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 492933
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 8529
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 738
6 GRAPHIC exhibit99-3x001.jpg GRAPHIC 4105
7 GRAPHIC exhibit99-4xu001.jpg GRAPHIC 140302
  Complete submission text file 0001062993-20-002437.txt   1152966
Mailing Address 520 WILLIAM STREET COBOURG A6 K9A 3A5
Business Address 520 WILLIAM STREET COBOURG A6 K9A 3A5 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 20881883
SIC: 2833 Medicinal Chemicals & Botanical Products